BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32067580)

  • 1. Memantine Protects From Exacerbation of Ischemic Stroke and Blood Brain Barrier Disruption in Mild But Not Severe Hyperhomocysteinemia.
    Gu SX; Sonkar VK; Katare PB; Kumar R; Kruger WD; Arning E; Bottiglieri T; Lentz SR; Dayal S
    J Am Heart Assoc; 2020 Feb; 9(4):e013368. PubMed ID: 32067580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.
    Lentz SR; Erger RA; Dayal S; Maeda N; Malinow MR; Heistad DD; Faraci FM
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H970-5. PubMed ID: 10993757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of retinal vasculature in cystathionine-Beta-synthase mutant mice, a model of hyperhomocysteinemia.
    Tawfik A; Al-Shabrawey M; Roon P; Sonne S; Covar JA; Matragoon S; Ganapathy PS; Atherton SS; El-Remessy A; Ganapathy V; Smith SB
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):939-49. PubMed ID: 23307965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.
    Hamelet J; Demuth K; Paul JL; Delabar JM; Janel N
    J Hepatol; 2007 Jan; 46(1):151-9. PubMed ID: 17030070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.
    Jindal A; Rajagopal S; Winter L; Miller JW; Jacobsen DW; Brigman J; Allan AM; Paul S; Poddar R
    Neurobiol Dis; 2019 Jul; 127():287-302. PubMed ID: 30885791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.
    Chen HS; Wang YF; Rayudu PV; Edgecomb P; Neill JC; Segal MM; Lipton SA; Jensen FE
    Neuroscience; 1998 Oct; 86(4):1121-32. PubMed ID: 9697119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
    Dayal S; Bottiglieri T; Arning E; Maeda N; Malinow MR; Sigmund CD; Heistad DD; Faraci FM; Lentz SR
    Circ Res; 2001 Jun; 88(11):1203-9. PubMed ID: 11397788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of betaine in a murine model of mild cystathionine-beta-synthase deficiency.
    Schwahn BC; Wendel U; Lussier-Cacan S; Mar MH; Zeisel SH; Leclerc D; Castro C; Garrow TA; Rozen R
    Metabolism; 2004 May; 53(5):594-9. PubMed ID: 15131763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid.
    Kalani A; Kamat PK; Givvimani S; Brown K; Metreveli N; Tyagi SC; Tyagi N
    J Mol Neurosci; 2014 Feb; 52(2):202-15. PubMed ID: 24122186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency.
    Kelly PJ; Furie KL; Kistler JP; Barron M; Picard EH; Mandell R; Shih VE
    Neurology; 2003 Jan; 60(2):275-9. PubMed ID: 12552044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkeratosis in cystathionine beta synthase-deficient mice: an animal model of hyperhomocysteinemia.
    Robert K; Maurin N; Ledru A; Delabar J; Janel N
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):1072-6. PubMed ID: 15386278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous elevation of homocysteine induces retinal neuron death in the cystathionine-beta-synthase mutant mouse.
    Ganapathy PS; Moister B; Roon P; Mysona BA; Duplantier J; Dun Y; Moister TK; Farley MJ; Prasad PD; Liu K; Smith SB
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4460-70. PubMed ID: 19357353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia.
    Gupta S; Kühnisch J; Mustafa A; Lhotak S; Schlachterman A; Slifker MJ; Klein-Szanto A; High KA; Austin RC; Kruger WD
    FASEB J; 2009 Mar; 23(3):883-93. PubMed ID: 18987302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke injury induced by distal middle cerebral artery occlusion is resistant to N-methyl-d-aspartate receptor antagonism in FVB/NJ mice.
    Liu CW; Liao KH; Wu CM; Chen HY; Wang EY; Lai TW
    Neuroreport; 2021 Sep; 32(13):1122-1127. PubMed ID: 34284452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
    Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
    Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death.
    Marutani E; Kosugi S; Tokuda K; Khatri A; Nguyen R; Atochin DN; Kida K; Van Leyen K; Arai K; Ichinose F
    J Biol Chem; 2012 Sep; 287(38):32124-35. PubMed ID: 22815476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitration-mediated deficiency of cystathionine β-synthase activity accelerates the progression of hyperhomocysteinemia.
    Wang H; Sun Q; Zhou Y; Zhang H; Luo C; Xu J; Dong Y; Wu Y; Liu H; Wang W
    Free Radic Biol Med; 2017 Dec; 113():519-529. PubMed ID: 29102635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol.
    Culmsee C; Junker V; Kremers W; Thal S; Plesnila N; Krieglstein J
    Stroke; 2004 May; 35(5):1197-202. PubMed ID: 15060319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
    Kamat PK; Kyles P; Kalani A; Tyagi N
    Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuronal SAPK/JNK pathway is altered in a murine model of hyperhomocysteinemia.
    Robert K; Santiard-Baron D; Chassé JF; Paly E; Aupetit J; Kamoun P; London J; Janel N
    J Neurochem; 2004 Apr; 89(1):33-43. PubMed ID: 15030387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.